These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Allergic contact dermatitis from sodium fusidate with no underlying dermatosis. Lee AY; Joo HJ; Oh JG; Kim YG Contact Dermatitis; 2000 Jan; 42(1):53. PubMed ID: 10644035 [No Abstract] [Full Text] [Related]
4. Sodium fusidate. S Afr Med J; 1969 Dec; 43(51):1537. PubMed ID: 5372049 [No Abstract] [Full Text] [Related]
5. Sodium fusidate and the cytokine response in an experimental model of acute pancreatitis. Widdison AL Br J Surg; 1999 May; 86(5):715. PubMed ID: 10361358 [No Abstract] [Full Text] [Related]
6. Rhabdomyolysis secondary to interaction of fusidic acid and simvastatin. Yuen SL; McGarity B Med J Aust; 2003 Aug; 179(3):172. PubMed ID: 12885276 [No Abstract] [Full Text] [Related]
7. A timely reminder about the concomitant use of fusidic acid with statins. Cowan R; Johnson PD; Urbancic K; Grayson ML Clin Infect Dis; 2013 Jul; 57(2):329-30. PubMed ID: 23588554 [No Abstract] [Full Text] [Related]
8. Pharmacokinetics and tolerance of a new film-coated tablet of sodium fusidate administered as a single oral dose to healthy volunteers. Macgowan AP; Greig MA; Andrews JM; Reeves DS; Wise R J Chemother; 1989 Jul; 1(4 Suppl):593-6. PubMed ID: 16312548 [No Abstract] [Full Text] [Related]
9. Fatal rhabdomyolysis following the co-prescription of fusidic acid and pravastatin. Bachoumas K; Fiancette M; Lascarrou JB; Lacherade JC; Leclair F; Reignier J Med Mal Infect; 2015 Oct; 45(10):417-9. PubMed ID: 26472060 [No Abstract] [Full Text] [Related]
10. A randomized, double-blind phase 2 study comparing the efficacy and safety of an oral fusidic acid loading-dose regimen to oral linezolid for the treatment of acute bacterial skin and skin structure infections. Craft JC; Moriarty SR; Clark K; Scott D; Degenhardt TP; Still JG; Corey GR; Das A; Fernandes P Clin Infect Dis; 2011 Jun; 52 Suppl 7():S520-6. PubMed ID: 21546629 [TBL] [Abstract][Full Text] [Related]
11. The safety record of fusidic acid in non-US markets: a focus on skin infections. Kraus CN; Burnstead BW Clin Infect Dis; 2011 Jun; 52 Suppl 7():S527-37. PubMed ID: 21546630 [TBL] [Abstract][Full Text] [Related]
12. Immunoadsorption therapy for steroid-unresponsive relapses in patients with multiple sclerosis. Trebst C; Bronzlik P; Kielstein JT; Schmidt BM; Stangel M Blood Purif; 2012; 33(1-3):1-6. PubMed ID: 22086365 [TBL] [Abstract][Full Text] [Related]
13. Fusidic acid cream for impetigo. Emergence of resistance to fusidic acid limits its use. Weston VC; Boswell TC; Finch RG; Perkins W BMJ; 2002 Jun; 324(7350):1394. PubMed ID: 12053928 [No Abstract] [Full Text] [Related]
14. Increasing rate of detection of fusidic acid resistance in methicillin-resistant Staphylococcus aureus isolated from clinical samples in Malaysia. Alreshidi MA; Mariana NS Med J Malaysia; 2011 Aug; 66(3):276. PubMed ID: 22111461 [No Abstract] [Full Text] [Related]
16. [Bacteriological studies in the therapy of treatment-resistant staphylococcal infections with fusidic acid]. Roser H Med Welt; 1967 May; 21():1325-9. PubMed ID: 5612546 [No Abstract] [Full Text] [Related]
17. [Cholestatic icterus induced by the administration of fusidic acid in a cirrhotic patient]. Carbonell N; Thabut D; Podevin P; Biour M; Serfaty L; Poupon R Presse Med; 2002 Jun; 31(23):1083-4. PubMed ID: 12148265 [TBL] [Abstract][Full Text] [Related]
18. Intranasal administration of fusidic acid cream in leprosy. Mahajan PM; Jadhav VH; Jogaikar DG; Mehta JM Indian J Lepr; 2000; 72(4):451-5. PubMed ID: 11212479 [TBL] [Abstract][Full Text] [Related]
19. High usage of topical fusidic acid and rapid clonal expansion of fusidic acid-resistant Staphylococcus aureus: a cautionary tale. Williamson DA; Monecke S; Heffernan H; Ritchie SR; Roberts SA; Upton A; Thomas MG; Fraser JD Clin Infect Dis; 2014 Nov; 59(10):1451-4. PubMed ID: 25139961 [TBL] [Abstract][Full Text] [Related]